GLP-1/glucagon dual receptor agonist studied in obesity and liver-metabolism research.
⚠ For research use only · Not for human use · Not FDA approved
A short research-handling guide for Survodutide. For laboratory and research use only.
GLP-1/glucagon dual receptor agonist studied in obesity and liver-metabolism research.
Survodutide is supplied as a lyophilized (freeze-dried) powder. Reconstitute it before research use. Recommended diluent: bacteriostatic water.
Example: 2 ml of diluent in this 2 mg vial gives 1,000 mcg/ml. A 600 mcg research amount is then 0.6 ml (60 units on a U-100 syringe) — about 3 doses per vial.
Most commonly referenced in published research at 600–2,000 mcg, once weekly. Reference only — not a dosing instruction.
Keep lyophilized vials frozen and out of light. Once reconstituted, refrigerate (2–8 °C) and use within a few weeks. Always use sterile technique.
For laboratory and research use only. Not for human or veterinary use, food, or drug applications.